Phathom Pharmaceuticals, Inc. insider trading

PHATNASDAQ

$6.70-0.22 (-3.18% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-42.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

JNJames N. TopperDirector7.3639%of company
ANAzmi NabulsiChief Operating Officer1.362%of company
SLSteven L. BastaPresident and CEO0.4614%of company
TCTerrie CurranPresident and Chief Executive0.4503%of company
SNSanjeev NarulaChief Financial & Bus. Officer0.2802%of company
APAsit ParikhDirector0.2134%of company
MHMolly HendersonCFO and CBO0.1134%of company
FKFrank KarbeDirector0.1133%of company
AMAnne Marie CookChief Legal Off. & Corp. Sec.0.1096%of company
RCRobert Charles BreedlovePrincipal Accounting Officer0.0836%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
PHAT	Robert Charles BreedlovePrincipal Accounting Officer	Open market sell$7.08K	-1.0%	$13.51	$7.08K	Nov 3, 2025	Nov 5, 2025

End of history · 1 transactions